The net effect of acromegaly on inflammation and CVD seems to be influenced by disease control (GH/IGF-1 levels), concomitant metabolic disturbances, hormonal deficiencies, age and gender [104, 105], which illustrates the complex mechanisms and interactions with GH/IGF-1 and other factors. The gene discussed is IGF1; the disease is acromegaly.